What is the primary reason for monitoring urine output in a client receiving intravenous amphotericin B?

Monitoring urine output in a client receiving intravenous amphotericin B is primarily focused on assessing for nephrotoxicity. Amphotericin B is known to have a significant risk of causing kidney damage, and one of the key indicators of renal function is the amount of urine produced. An adequate urine output signifies that the kidneys are functioning properly, while decreased urine output may indicate potential renal impairment. Early detection of nephrotoxicity is crucial, as it allows for timely intervention, which may include adjusting the dosage of the drug or implementing supportive measures to protect kidney function.

While hydration status and electrolyte balance are important considerations in patients receiving amphotericin B, these factors are often assessed through other means or are secondary to directly monitoring renal function through urine output. Although infections can occur due to underlying conditions or compromised immune systems, they do not serve as the primary reason for monitoring urine output in relation to the use of this specific antifungal medication. Therefore, nephrotoxicity is the key reason for urine output monitoring in this context.